This free CME webinar was developed in response to changes made by the Substance Abuse and Mental Health Services Administration (SAMHSA) to the 42 CFR Part-2 confidentiality rule.
Upon completion of this activity, participants should be able to:
- Explain recent changes to the 42 CFR Part-2 confidentiality rule.
- Describe how changes to the rule further integrate addiction treatment into the health care system.
- Appraise which treatment programs are subject to the final 42 CFR Part-2 rule.
- Differentiate circumstances in which health providers can disclose patient treatment information.
- Define “general designation” as a collective group of medical professionals with disclosure privileges.
- Identify health service providers that are defined as a qualified service organizations under the revised 42 CFR Part-2 rule.
- Explain a patient’s right to request lists of professionals given “general designation” privileges and those with access to health information.
- Addiction medicine specialists
- Opioid treatment program providers
- DATA-waived provider
- Public health management services providers
AMA Credit Designation Statement:
The American Society of Addiction Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ACCME Accreditation Statement:
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.